Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer

NCT06777537 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT06777537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06777537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
December 1, 2030
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer